MARINUS PHARMACEUTICALS, INC revenue for the last year amounted to 526.35 M MXN, the most of which — 526.35 M MXN — came from its highest performing source at the moment, Therapeutics for Rare Seizures, the year earlier bringing 496.94 M MXN. The greatest contribution to the revenue figure was made by United States — last year it brought MARINUS PHARMACEUTICALS, INC 526.35 M MXN, and the year before that — 496.94 M MXN.